UPDATE 1-Moderna CEO says vaccines likely less effective against Omicron - FT




 

* Drugmaker CEO warns of "material drop" in vaccine effectiveness 

  * Mutations mean existing vaccines likely need modifying - CEO 

  * Financial markets drop (Adds background) 

  SYDNEY, Nov 30 (Reuters) - The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic. 

  "There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta," Moderna Chief Executive Stéphane Bancel told the Financial Times https://www.ft.com/content/27def1b9-b9c8-47a5-8e06-72e432e0838f in an interview. 

  "I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'" 

  Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar. 

  Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified. 

  He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron. 

  Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions. [nL1N2SL045 

  (Reporting by Tom Westbrook; Editing by Kim Coghill) 

COMMENTS

More Related News

Surging Real Yields Jar Markets Eyeing End of Easy-Money Era
Surging Real Yields Jar Markets Eyeing End of Easy-Money Era

(Bloomberg) -- Inflation-adjusted Treasury yields have surged back from record lows, sending tremors across financial markets preparing for an era of...

Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study
Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study
  • US
  • 2022-01-20 15:31:34Z

A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not...

One chart shows people vaccinated with Moderna had the best protection against COVID in 2021
One chart shows people vaccinated with Moderna had the best protection against COVID in 2021

The huge new CDC dataset backs up what other studies have found, that Moderna is edging out Pfizer and J&J is offering less protection against COVID.

Analysis-How Omicron highlights fading hope of herd immunity from COVID
Analysis-How Omicron highlights fading hope of herd immunity from COVID
  • US
  • 2022-01-20 11:03:07Z

The Omicron variant, which is spreading far faster than previous versions of the coronavirus, is not likely to help countries achieve so-called herd immunity...

Primark to cut 400 store management jobs
Primark to cut 400 store management jobs

The retailer saw sales fall as the spread of Omicron cut the number of visitors to its shops.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Economy